1
ChronicObstructivePulmonaryDiseaseasaRiskFactorforCardiovascularMorbidityandMortality
DonD.SinandS.F.PaulMan
DepartmentofMedicine,UniversityofBritishColumbia;andTheJamesHoggiCAPTURECenterforCardiovascularandPulmonaryResearch,St.Paul’sHospital,Vancouver,BritishColumbia,Canada
Chronicobstructivepulmonarydiseaseandotherdisorders,associ-atedwithreducedlungfunction,arestrongriskfactorsforcardio-vascularevents,independentofsmoking.Overall,whenthelowestquintileoflungfunction,asmeasuredbyFEV1,iscomparedwiththehighestquintile,theriskofcardiovascularmortalityincreasesbyapproximately75%inbothmenandwomen.Havingsymptomsofchronicbronchitisaloneincreasestheriskofcoronarydeathsby50%.ReducedratioofFEV1toFVCbyitselfisamodestindependentriskfactorforcoronaryevents,increasingtheriskby30%.However,ifpatientshaveventriculararrhythmias,theriskofcoronaryeventsisincreasedtwofold,suggestingthatthecardiotoxiceffectsofob-structiveairwaysdiseaseareamplifiedinthosewhohaveunderlyingcardiacrhythmdisturbances.Ingeneral,forevery10%decreaseinFEV1,all-causemortalityincreasesby14%,cardiovascularmortalityincreasesby28%,andnonfatalcoronaryeventincreasesbyalmost20%.Thesedataindicatethatchronicobstructivepulmonarydis-easeisapowerful,independentriskfactorforcardiovascularmor-bidityandmortality.
Keywords:cardiovasculardisease;chronicobstructivepulmonarydis-ease;epidemiology;FEV1;lungfunction
Chronicobstructivepulmonarydisease(COPD)affectsover5%oftheadultpopulationandistheonlymajorcauseofdeathintheUnitedStatesandelsewherewhosemorbidityandmortalityareincreasing(1,2).COPDaffectsover16millionpeopleintheUnitedStatesanditsprevalencehasrisenby41%since1982,whiletheage-adjusteddeathratehasincreasedby17%between1966and1982(1).COPDaccountsforapproximately750,000hospitalizationseveryyearintheUnitedStates,and10to12%ofthesestaysoccurincriticalcareunits(1).Theeco-nomiccostsforCOPDare$24billionperannumintheUnitedStates;directmedicalexpenditures(relatedmostlytohospital-basedcare)accountfor61%ofthetotalcosts(3).Unfortunately,thebestforecastssuggestthattheburdenofCOPDintheUnitedStatesandelsewherewillcontinuetoescalateoverthenext20to30years.Infact,by2020,theWorldHealthOrganizationpredictsthatCOPDwillbecomethethirdleadingcauseofdeath(currentlyfourth)andthe fthleadingcauseofdisability(cur-rentlytwelfth)worldwide(4,5).Ironically,NationalInstitutesofHealthfundingofresearchinCOPDiscurrentlythelowestamongallmajorcausesofmortalityinNorthAmerica(6).Althoughthese guresonCOPDmorbidityandmortalityarealarming,theyareonlya“tipoftheiceberg,”becauseair owobstructionisanimportantcontributortoothercommoncauses
(ReceivedinoriginalformApril29,2004;acceptedinfinalformJuly9,2004)D.D.S.issupportedbyaCanadaResearchChair(ObstructiveAirwayDisease)andaMichaelSmith/St.Paul’sHospitalFoundationProfessorshipinCOPD.
CorrespondenceandrequestsforreprintsshouldbeaddressedtoDonD.Sin,M.D.,JamesHoggiCAPTURECenterforCardiovascularandPulmonaryResearch,St.Paul’sHospital,Room#368A,1081BurrardStreet,Vancouver,BC,V6Z1Y7Canada.E-mail:dsin@mrl.ubc.ca
ProcAmThoracSocVol2.pp8–11,2005DOI:10.1513/pats.200404-032MS
Internetaddress:doc.guandang.net
ofmorbidityandmortality.Datafrommultiplestudiesacrossdifferentjurisdictionsindicatethatoneoftheleadingbutunder-recognizedcausesofdeathinCOPDisischemicheartdisease(7–9).Largepopulation-basedstudiessuggestthatpatientswithCOPDaretwotothreetimesmoreatriskforcardiovascularmortality,whichaccountsforabout50%ofthetotalnumberofdeaths(8,10,11).Indeed,althoughnotgenerallyrecognized,poorlungfunctionhasbeenshowntobeaspowerfulapredictorofcardiacmortalityasestablishedriskfactorssuchastotalserumcholesterol(12).Inviewoftherelevanceofcardiovascularout-comesinpatientswithCOPD,inthepresentsection,wewillsystematicallyandcriticallyreviewtheepidemiologiclinkbe-tweenCOPDandcardiovascularmorbidityandmortality.
THERELATIONSHIPBETWEENFEV1ANDCARDIOVASCULARDISEASE
IndividualswithreducedFEV1areatincreasedriskforathero-sclerosis.Zureikandcolleagues(13)performedacross-sectionalstudyon194healthy,middle-agedmenfreeofcoronaryheartdiseasetodeterminetherelationshipbetweenFEV1andpulsewavevelocity,asurrogatemeasurementforcentralarterialstiff-ness,endothelialdysfunction,andatherosclerosis.Theyshowedthatindependentofotherwellestablishedriskfactorsforathero-sclerosis,reducedFEV1wasassociatedwithincreasedpulsewavevelocity.Foreverydecrementof193mlinFEV1,theparticipants’pulsewavevelocityincreasedby2.5meterspersecond.FEV1accountedfor6.8%ofthetotalvariationinthepulsewavevelocity.ReducedFEV1/FVCratiowasalsonegativelyrelatedtopulsewavevelocity,suggestingthatairwaysdiseasewasanindependentriskfactorforcentralarterialstiffness.
SeveralgroupshavereportedontherelationshipbetweenFEV1andcardiovascularmortalityusingpopulation-basedstud-ies.TheHonoluluHeartProgram(14)prospectivelyfollowed5,924generallyhealthy,middle-agedmen(abouthalfwerecur-rentsmokers)for15to18years.TheyfoundthatcomparedtothoseinthehighestquintileofFEV1,individualsinthelowestFEV1quintilehadanelevatedriskofcardiovascularmortality(relativerisk[RR],1.93;95%con denceinterval[CI],1.46–2.54).HigginsandKeller(15),usingtheTecumsehCohort,re-portedastrongerassociation.ComparedtothosewithFEV1greaterthanorequalto2.0L,thosewithFEV1lessthan2.0Lhada vefoldincreaseintheRRofcardiovascularmortality(RR,5.03;95%CI,3.07–8.22).IntheHarvardSixCitiesStudy,Speizerandcolleagues(16)reportedanRRof2.74(95%CI,1.93–3.90)inwomenand1.42(95%CI,1.07–1.90)inmen,com-paringthelowestFEV1quartiletothehighestquartile.However,thesestudieswererelativelyold,raisingsomeconcernsthattime-publicationbiasmayhaveaccountedforthese ndings.Toaddressthisconcern,inTable1,wehavesummarizedresultsfromstudiespublishedsince1990thathaveevaluatedtherela-tionshipbetweenFEV1andcardiovascularmortality(12,17–19).IntheBuffalocohort,forinstance,Schunemannandcolleagues(17)reportedanRRof1.96(95%CI,0.99–3.88)inwomenand2.11(95%CI,1.20–3.71)inmen,onceagaincomparingthelowestFEV1quintiletothehighestquintile.Holeandcolleagues
Trends Mol Med 7:55–62 Sin DD, Man SFP (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases?...
(Chronic Obstructive Pulmonary Disease) is the most common pulmonary disorder ...cardiac disease and should also receive a careful cardiovascular evaluation . ...
as a risk factor for a subsequent CABG procedure...TABLE 1 Patient Demographics, Cardiovascular Risk ...chronic obstructive pulmonary disease; MI, myocardial...
Pulmonary Perspective Chronic Obstructive Pulmonary Disease and Obstructive Sleep ...Chronic obstructive pulmonary disease as a risk factor for cardiovascular ...
OBSTRUCTIVE SLEEP APNEA SYNDROME 1 Department of ...independent risk factor for cardiovascular diseases ...without any acute or chronic disease, using no ...
( 〔 6〕 Stone IS,Barnes NC,Petersen SE. Chronic obstructive pulmonary ? disease: a modifiable risk factor for cardiovascular Disease 〔J〕 Heart, 2012...
Keywords: COPD, atherothrombosis, cardiovascular risk, mortality Introduction Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide...
Methods We assessed the risk of death and major cardiovascular (CV) events associated with chronic obstructive pulmonary and results disease in 14 703 ...
Berka, Jian-Dong Lib,2, and Chen Yana,2 a Aab Cardiovascular Research ...ammatory diseases (e.g., chronic obstructive pulmonary disease, asthma) (2...
Cigarette smoking is the most important risk factor for the development of chronic obstructive pulmonary disease (COPD) and lung cancer, but only a part ...
热门文档